Jeff Yass’s Pandion Therapeutics Inc. Common Stock PAND Stock Holding History

Jeff Yass’s Portfolio PAND Stock Details PAND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-19,584	Closed	-$1.18M	–	13738
2021 Q1	$1.18M	Buy	+19,584	New	+$709K	﹤0.01%	7288
2020 Q4	–	Sell	-16,619	Closed	-$190K	–	12021
2020 Q3	$190K	Buy	+16,619	New	+$284K	﹤0.01%	9499

Jeff Yass's PAND Position: Q2 2021 in Review

Jeff Yass sold out of Pandion Therapeutics Inc. Common Stock (PAND) in Q2 2021, closing a stake of 19,584 shares — an estimated $1.18M sold.

Jeff Yass first reported a position in PAND in Q3 2020 and held it in 2 quarters. The position peaked at $1.18M in Q1 2021. 0 funds tracked by Wall St. Rank hold PAND as of Q2 2021.

Jeff Yass reported no remaining Pandion Therapeutics Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
Jeff Yass sold 19,584 Pandion Therapeutics Inc. Common Stock shares in Q2 2021, an estimated $1.18M.
Jeff Yass first reported a position in Pandion Therapeutics Inc. Common Stock in Q3 2020 and held it in 2 quarters.
Jeff Yass's Pandion Therapeutics Inc. Common Stock position peaked at $1.18M in Q1 2021.
0 funds tracked by Wall St. Rank held Pandion Therapeutics Inc. Common Stock as of Q2 2021.

Based on Susquehanna International Group's 13F filing for Q2 2021, filed 11 Aug 2021.